Global Stem Cells Group is pleased to announce the establishment of a cell therapy and regenerative medicine facility in Indonesia.
Global Stem Cells Group is pleased to announce the establishment of a cell therapy and regenerative medicine facility in Indonesia. The new facility emphasizes Global Stem Cell Group's objectives of bringing the advances and benefits of regenerative medicine to parts of the world where they are less well known.
By enabling cooperation with Dr. Yanti Kusmiran Clinic in Indonesia , this new center will promote high standards of service in Regenerative medicine across Indonesia.
This center is part of an expanding medical network of partners, and it will formalize and strengthen ties, establishing a global center of excellence to guarantee that we effectively use the underlying basic stem cell technology for medical conditions where traditional therapeutic approaches seem to have failed . This is consistent with the GSCG's overall strategy for developing regenerative medicine through data-driven studies, disease modeling, and cell-based therapeutics.
There wouldn't have been a better partner to go sign this deal with, Dr. Yanti Aesthetic Clinic provides the organizational and physical infrastructure needed to disseminate need-based stem cell and gene therapies locally. And Global Stem Cells Group's outstanding cell and stem cell biology and disease pathophysiology give an edge to any patient they're prescribed to.
GSCG has developed an enviable reputation in regenerative medicine. So, this presents the perfect opportunity to translate breakthrough therapies from basic discoveries to useful products drawing on the skills and local knowledge of Dr. Yanti Aesthetic Clinics.
Group managing director Benito Novas provided the clearest description of the new strategic direction and GSCG's objectives.“Our main goal is to make regenerative medicine benefits a reality for both doctors and patients all around the world. The company is expanding and establishing itself as a market leader.”
The current market outlook
Cell therapies are becoming an increasingly effective and safe clinical solution to treat conditions that traditional medicine offers only palliative care. That is why patients all over the world are looking for a natural regenerative alternative without the use of drugs and medicines. . However, its application is still in its early stages. Moves like this one try to reduce the impediments to widespread adoption. This effort will play a significant role in the development of regenerative medicine in Indonesia, allowing for continuous improvement through research and development.
Dr. Yanti Aesthetic Clinics
Dr. Yanti Aesthetic Clinics is a premier cosmetic and aesthetics clinic in Kelapa Gading, Jakarta Utara. Since its inception in 2004 in Surabaya by Dr. Khoe Yanti Khusmiran , the hospital has expanded to over 6 branches throughout Indonesia. They provide a range of skin and body enhancement treatments and stand to gain from stem cell therapies for their minimally invasive and non-invasive procedures.
The newly formed association will deliver revolutionary medicines through these clinics to assist patients in avoiding permanent harm and live healthy lives. Changing the paradigm from asymptomatic treatments to cures that improve quality of life. Dr. Yanti Kushmiran was enthusiastic about this announcement. He said,“We are honored to be a part of GSCG, which has an over 10-year track record in the market and a strong international reputation. We will provide more services to our patients because of this new partnership.”
Global Stem Cells Group
GSCG delivers leadership in regenerative medicine research, patient applications, and training through our strategic global networks. We endeavor to enable physicians to treat otherwise incurable diseases using stem cell therapy and to improve the quality of life and care across the world.
For this reason, we work with innovative next-generation therapy providers like Dr. Yanti Aesthetic Clinics to give access to one-of-a-kind holistic, and safe, treatment options.
More information regarding this transaction and the Global Stem Cells Group may be found at GSCG.
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.